Calamos Advisors’s Axogen AXGN Stock Holding History

Calamos Advisors’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.39M	Buy	+95,146	New	+$3.84M	0.01%	566
2025 Q2	–	Sell	-40,789	Closed	-$755K	–	920
2025 Q1	$755K	Buy	40,789 +9,064	+29%	+$164K	﹤0.01%	679
2024 Q4	$523K	Buy	+31,725	New	+$449K	﹤0.01%	725
2021 Q2	–	Sell	-145,600	Closed	-$2.95M	–	958
2021 Q1	$2.95M	Buy	145,600 +72,062	+98%	+$1.42M	0.02%	643
2020 Q4	$1.32M	Buy	+73,538	New	+$1.08M	0.01%	668

Other funds holding AXGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Calamos Advisors's AXGN Position: Q2 2026 in Review

Calamos Advisors opened a new position in Axogen (AXGN) in Q2 2026: 95,146 shares worth $4.39M. The stake represents 0.01% of the portfolio and ranks #566 among its holdings. This is a return to the name: Calamos Advisors previously reported a position in AXGN as recently as Q1 2025.

Calamos Advisors first reported a position in AXGN in Q4 2020 and has held it in 5 quarters since. 254 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

Calamos Advisors held 95,146 shares of Axogen worth $4.39M as of Q2 2026.
Axogen was a new Calamos Advisors position in Q2 2026.
Axogen made up 0.01% of Calamos Advisors's portfolio in Q2 2026, its #566 holding.
Calamos Advisors first reported a position in Axogen in Q4 2020 and has held it in 5 quarters since.
254 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.